Mark Coleman is of Axsome Therapeutics, Inc.. Currently has a direct ownership of 48,010 shares of AXSM, which is worth approximately $4.18 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 33,410 shares (Common Stock) at a price of $5.94 per share, resulting in proceeds of $198,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48K
228.84% 3M change
91.3% 12M change
Total Value Held $4.18 Million

Mark Coleman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2024
BUY
Exercise of conversion of derivative security
$198,455 $5.94 p/Share
33,410 Added 41.03%
48,010 Common Stock
May 29 2024
SELL
Open market or private sale
$394,334 $75.14 p/Share
5,248 Reduced 26.44%
14,600 Common Stock
May 28 2024
SELL
Open market or private sale
$394,777 $75.21 p/Share
5,249 Reduced 20.91%
19,848 Common Stock
Sep 15 2023
SELL
Open market or private sale
$828,293 $75.19 p/Share
11,016 Reduced 30.5%
25,097 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
$40,428 $3.67 p/Share
11,016 Added 23.37%
36,113 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$22,751 $1.3 p/Share
17,501 Added 41.08%
25,097 Common Stock
Mar 15 2022
BUY
Exercise of conversion of derivative security
$4,545 $1.3 p/Share
3,496 Added 31.52%
7,596 Common Stock
MC

Mark Coleman

New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM